Logo image of ELMD

ELECTROMED INC (ELMD) Stock Fundamental Analysis

USA - NYSEARCA:ELMD - US2854091087 - Common Stock

24.39 USD
-0.31 (-1.26%)
Last: 9/16/2025, 8:04:00 PM
24.39 USD
0 (0%)
After Hours: 9/16/2025, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, ELMD scores 6 out of 10 in our fundamental rating. ELMD was compared to 191 industry peers in the Health Care Equipment & Supplies industry. ELMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ELMD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ELMD had positive earnings in the past year.
ELMD had a positive operating cash flow in the past year.
ELMD had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ELMD reported negative operating cash flow in multiple years.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

ELMD has a Return On Assets of 13.65%. This is amongst the best in the industry. ELMD outperforms 95.29% of its industry peers.
Looking at the Return On Equity, with a value of 16.30%, ELMD belongs to the top of the industry, outperforming 91.62% of the companies in the same industry.
With an excellent Return On Invested Capital value of 15.35%, ELMD belongs to the best of the industry, outperforming 95.81% of the companies in the same industry.
ELMD had an Average Return On Invested Capital over the past 3 years of 8.56%. This is in line with the industry average of 8.46%.
The last Return On Invested Capital (15.35%) for ELMD is above the 3 year average (8.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.65%
ROE 16.3%
ROIC 15.35%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELMD has a Profit Margin of 11.66%. This is amongst the best in the industry. ELMD outperforms 87.43% of its industry peers.
ELMD's Profit Margin has improved in the last couple of years.
ELMD's Operating Margin of 14.58% is amongst the best of the industry. ELMD outperforms 84.82% of its industry peers.
ELMD's Operating Margin has improved in the last couple of years.
ELMD has a better Gross Margin (77.55%) than 91.10% of its industry peers.
ELMD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.58%
PM (TTM) 11.66%
GM 77.55%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELMD is creating some value.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 17.51 indicates that ELMD is not in any danger for bankruptcy at the moment.
ELMD has a better Altman-Z score (17.51) than 94.76% of its industry peers.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.51
ROIC/WACC1.77
WACC8.69%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ELMD has a Current Ratio of 5.19. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ELMD (5.19) is better than 77.49% of its industry peers.
A Quick Ratio of 4.84 indicates that ELMD has no problem at all paying its short term obligations.
The Quick ratio of ELMD (4.84) is better than 80.63% of its industry peers.
Industry RankSector Rank
Current Ratio 5.19
Quick Ratio 4.84
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.83% over the past year.
The Earnings Per Share has been growing by 17.82% on average over the past years. This is quite good.
EPS 1Y (TTM)44.83%
EPS 3YN/A
EPS 5Y17.82%
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.27%

3.2 Future

The Earnings Per Share is expected to grow by 15.33% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.48% on average over the next years. This is quite good.
EPS Next Y17.51%
EPS Next 2Y15.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.69%
Revenue Next 2Y12%
Revenue Next 3Y9.48%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.04, the valuation of ELMD can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ELMD indicates a somewhat cheap valuation: ELMD is cheaper than 74.35% of the companies listed in the same industry.
ELMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 24.71, the valuation of ELMD can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELMD indicates a somewhat cheap valuation: ELMD is cheaper than 74.87% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.71. ELMD is around the same levels.
Industry RankSector Rank
PE 29.04
Fwd PE 24.71
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

75.92% of the companies in the same industry are more expensive than ELMD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ELMD is valued cheaply inside the industry as 88.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.22
EV/EBITDA 18.96
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ELMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ELMD has an outstanding profitability rating, which may justify a higher PE ratio.
ELMD's earnings are expected to grow with 15.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.66
PEG (5Y)1.63
EPS Next 2Y15.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ELMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ELECTROMED INC

NYSEARCA:ELMD (9/16/2025, 8:04:00 PM)

After market: 24.39 0 (0%)

24.39

-0.31 (-1.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)11-10 2025-11-10
Inst Owners50.06%
Inst Owner Change5.14%
Ins Owners7.54%
Ins Owner Change1.69%
Market Cap203.66M
Analysts82
Price Target35.7 (46.37%)
Short Float %4.27%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)2.94%
Max EPS beat(2)19.83%
EPS beat(4)4
Avg EPS beat(4)121.43%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)63.79%
EPS beat(12)8
Avg EPS beat(12)51.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.89%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.31%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.61%
Revenue beat(12)6
Avg Revenue beat(12)0.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.06%
PT rev (3m)-5.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0.77%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 29.04
Fwd PE 24.71
P/S 3.31
P/FCF 17.22
P/OCF 16.94
P/B 4.63
P/tB 4.7
EV/EBITDA 18.96
EPS(TTM)0.84
EY3.44%
EPS(NY)0.99
Fwd EY4.05%
FCF(TTM)1.42
FCFY5.81%
OCF(TTM)1.44
OCFY5.9%
SpS7.36
BVpS5.26
TBVpS5.19
PEG (NY)1.66
PEG (5Y)1.63
Profitability
Industry RankSector Rank
ROA 13.65%
ROE 16.3%
ROCE 20.38%
ROIC 15.35%
ROICexc 23.51%
ROICexgc 24%
OM 14.58%
PM (TTM) 11.66%
GM 77.55%
FCFM 19.25%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.7%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 19.8%
Cap/Sales 0.32%
Interest Coverage 250
Cash Conversion 120.96%
Profit Quality 165.17%
Current Ratio 5.19
Quick Ratio 4.84
Altman-Z 17.51
F-Score8
WACC8.69%
ROIC/WACC1.77
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.83%
EPS 3YN/A
EPS 5Y17.82%
EPS Q2Q%25%
EPS Next Y17.51%
EPS Next 2Y15.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.27%
Revenue Next Year13.69%
Revenue Next 2Y12%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
EBIT growth 1Y56.01%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year137.93%
EBIT Next 3Y45.86%
EBIT Next 5YN/A
FCF growth 1Y648.35%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y2942.32%
OCF growth 3Y43.37%
OCF growth 5Y28.48%